Funding for this research was provided by:
National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01 AR073208, R01 AR069572)
Received: 22 October 2020
Accepted: 11 February 2021
First Online: 25 February 2021
Ethics approval and consent to participate
: The Hopkins Lupus Cohort was approved on a yearly basis by the Johns Hopkins University School of Medicine Institutional Review Board (Study number NA_00039294).
: Not applicable.
: The authors (AAS, LCR, MP) report grants from the National Institutes of Health to support this work, during the conduct of the study. They report the following pending patents: “Autoimmune Antigens and Cancer” (AAS, LCR, AR) and “Materials and Methods for Assessing Cancer Risk and Treating Cancer” (AAS, TI, LCR, AR). They also report personal fees from Inova Diagnostics and Celgene, outside the submitted work (AR).